Martin Franklin, Ph.D.
Board Member
Director, Child and Adolescent OCD, Tic, Trich & Anxiety Group (COTTAGe), Department of Psychiatry, University of Pennsylvania
Associate Professor, Clinical Psychology in Psychiatry, University of Pennsylvania School of Medicine
Martin Franklin, Ph.D., is Clinical Director of Rogers Behavioral Health’s Philadelphia site and Associate Professor of Clinical Psychology in Psychiatry at the University of Pennsylvania School of Medicine. He has devoted the last three decades to understanding the phenomenology and treatment of OCD, anxiety, and related conditions across the developmental spectrum, and is one of the world’s leading experts in cognitive behavioral treatments for these disorders. He received continuous funding from the NIMH for almost twenty years to study the efficacy of treatments for pediatric OCD in particular. His recent treatment manual from Guilford Press, Franklin, Freeman, & March (2019), Treating OCD in Children and Adolescents: A Cognitive Behavioral Approach, is one of over 230 scientific papers, chapters, and books he has published.
Dr. Martin Franklin received his Ph.D. in clinical psychology from the University of Rhode Island. He has devoted his career to the study of anxiety and body-focused repetitive behaviors, such as chronic tic disorders and trichotillomania, in children and adults. His clinical and research careers have centered on these disorders, with an emphasis on developing and disseminating effective treatments.
Dr. Franklin has published theoretical, clinical and empirical papers and chapters, as well as treatment manuals. Currently, Dr. Franklin is a principal investigator of several multicenter studies funded by the National Institute of Mental Health, including an examination of Cognitive Behavioral Therapy augmentation in Serotonin Reuptake Inhibitors partial responders as well as an examination of the effectiveness of cognitive behavioral therapy for very young children with OCD. As the principal investigator on these multicenter studies, Dr. Franklin is a leading member of the Pediatric OCD Study team (POTS). The POTS team has set the precedent for the development of new practice guidelines for the treatment of OCD in youth through these momentous research projects.
In addition, Dr. Franklin piloted a study of habit reversal training (HRT) for tic disorders in adolescents and young adults funded by the Tourette Syndrome Association. He was central to the Trichotillomania Impact Project, a web-based exploration of phenomenology, functional impairment, and treatment utilization that reached over 1,600 individuals.
